Mayne Pharma Group Market Cap

Mayne Pharma Group has a market cap or net worth of 584.97 million as of February 21, 2025. Its market cap has increased by 33.33% in one year.

Market Cap

584.97M

Enterprise Value

474.51M

Revenue

388.40M

Ranking

n/a

PE Ratio

n/a

Stock Price

7.20

Market Cap Chart

Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 584.97M, an increase of 1,181.16%. That is a compound annual growth rate of 15.53%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	584.97M	44.87%
Dec 31, 2024	403.79M	-19.19%
Dec 29, 2023	499.66M	43.60%
Dec 30, 2022	347.96M	-33.16%
Dec 31, 2021	520.63M	-10.12%
Dec 31, 2020	579.28M	-20.69%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	125.25B
Pro Medicus	29.87B
Cochlear	17.59B
Sonic Healthcare	13.15B
Telix Pharmaceuticals	10.15B
Ramsay Health Care	7.87B
Ansell	5.19B
Mesoblast	3.38B

Market Cap Rankings